#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiectasis Angiosarcoma Vaginal cancer Follicular lymphoma stage III Synovial sarcoma Uveal melanoma Hypoxic-ischaemic encephalopathy Prodromal Alzheimer's disease Neurofibromatosis Mucopolysaccharidosis II Crohn's disease Krabbe's disease Congenital myopathy Ornithine transcarbamoylase deficiency Medulloblastoma recurrent More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS Loeys-Dietz syndrome – Treatment Ocular melanoma – Basic Information Usher’s syndrome – Treatment Progressive multifocal leukoencephalopathy – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Treatment Pulmonary fibrosis – Basic Information Fabry’s disease – Basic Information Hereditary motor and sensory neuropathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Irinotecan Hydrochloride Rbl035.2 Odevixibat Cobicistat Human Coagulation Factor Vii Trametinib Dimethyl Sulfoxide Guselkumab Islatravir Iodixanol Lamotrigine Guanfacine Nortriptyline Guanabenz Acetate GUAIACOL Clomipramine Hydrochloride Gliclazide Doxazosin Febuxostat Rp-1664 Sulfate Heparin Calcium More therapies…

    Learn about Your Condition

    Rectal cancer stage II Lyme disease Rett syndrome Cystic fibrosis Breast cancer in situ Astrocytoma malignant Migraine without aura Schizophreniform disorder Relapsing multiple sclerosis Hyperkalaemia Albuminuria Erythema multiforme Acne Pain Inclusion body myositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effectiveness of Talquetamab and Teclistamab in First-Line Treatment for Transplant-Eligible Multiple Myeloma Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Bortezomib
    • Daratumumab
    Denmark Estonia Norway

  • Study of BLU-263 and Azacitidine for Patients with Advanced Systemic Mastocytosis and Other KIT Altered Blood Cancers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • Blu-263 Phosphate
    • Azacitidine
    Belgium France Germany The Netherlands Norway Spain

  • Study on Crizanlizumab for Adolescents and Adults with Sickle Cell Disease Experiencing Vaso-Occlusive Crises

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Sickle cell disease
    Investigated Drugs:
    • Crizanlizumab
    Belgium Finland France The Netherlands Spain

  • Study on the Safety and Effectiveness of Quizartinib for Children and Young Adults with Acute Myeloid Leukemia (AML)

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia recurrent
    • Fms-like tyrosine kinase 3 positive
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    Belgium Denmark France Italy The Netherlands Spain +1

  • Study on the Safety and Effectiveness of Rilzabrutinib for Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP)

    Not recruiting

    3 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Rilzabrutinib
    France Germany Hungary Italy Norway Poland +1

  • A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Crizanlizumab
    Belgium France Germany Italy Spain
Previous Page
1 … 66 67 68 69 70 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!